Position in APGE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,903,166
New position
Shares Held
44,475
first reported quarter
Ownership
0.059%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#112
of 285 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Carmignac Gestion holds $277,738,773 across 9 Biotechnology names. APGE ranks #7 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
182,507 | $113,800,414 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
163,045 | $80,989,342 | |
| 3 | RPRX |
Royalty Pharma plc
|
630,700 | $35,363,349 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
321,000 | $25,452,090 | |
| 5 | TECH |
BIO-TECHNE Corp
|
124,530 | $8,798,044 | |
| 6 | BNTX |
BioNTech SE
|
79,875 | $7,432,368 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
This page
|
44,475 | $5,903,166 | |
| 8 | 95,603 | $0 |
All Filings in APGE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,903,166 | 44,475 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||